Recalling the evolutionary sequence of development first of gonad and subsequently of oviducts, ovarian endocrine regulation of all known components of oviduct physiology is reviewed. Ovaries not only influence oviducts via the systemic blood circulation, but also locally by counter-current transfer of relatively high concentrations of steroid hormones and prostaglandins between the ovarian vein and oviduct branch of the ovarian artery. The efficiency and impact of such counter-current transfer is greatest around the time of ovulation, the transfer process receiving further inputs from hormones present in peritoneal fluid. Classical oviduct physiology is summarised, and the potential molecular consequences of temperature gradients within the duct lumen examined. At ovulation, an oocyte-cumulus complex is displaced in minutes from the follicular surface to the site of fertilisation at the ampullary-isthmic junction of the oviduct. This rapid initial phase is contrasted with the subsequent slow progression of embryos to the uterus in days, still encompassed within a zona pellucida. Regarding transport of spermatozoa, the formation of a pre-ovulatory reservoir in the caudal portion of the oviduct isthmus is noted, with suppression of motility and sperm-head binding to epithelial organelles acting to maintain fertilising ability. Completion of capacitation is prompted shortly before ovulation, predominantly by Ca(2+) influx into bound spermatozoa. A controlled release of spermatozoa coupled with their hyperactivation results in initial sperm:egg ratios at the site of fertilisation close to unity, thereby avoiding the pathological condition of polyspermy. Both the oviduct milieu and embryonic development are influenced by paracrine activity of follicular granulosa cells released at ovulation and remaining in suspension in the vicinity of the oocyte or embryo. These cells may amplify early pregnancy signals from a zygote to the endosalpinx. Beneficial effects of the oviduct on domestic animal embryos are contrasted with anomalies arising as a consequence of in vitro culture. Primate embryos do not require exposure to an oviduct for normal development, perhaps due to overlapping compositions of endosalpingeal and endometrial secretions. Additionally, primate endometrial secretions may be modified by viable gametes or an embryo in the presence of a cumulus cell suspension.
The rate of establishment of a population of viable spermatozoa in the oviducts was studied using a technique of post-coital transection in conjunction with subsequent examination of the proportion of eggs fertilized. Gilts were mated early in oestrus (before ovulation) or on the 2nd day of oestrus (after ovulation), and 30, 45 or 60 min later the reproductive tract was sectioned just above or below the utero-tubal junction in a total of 48 animals; these were slaughtered 1 or 2 days after the operation. Some fertilized eggs were recovered from 40 animals, and 72.3% of the 679 eggs examined were fertilized. Mean percentage fertilization increased overall (a) with the time elapsing from mating to transection, (b) with transection below the utero-tubal junction compared with in the caudal isthmus, and (c) with a post-ovulatory versus pre-ovulatory mating. In a further 6 gilts, the results of transection in the lower third of the oviduct 3 h after mating at the onset of oestrus indicated that spermatozoa were initially sequestered in the caudal portion of the isthmus. It is concluded that a population of spermatozoa sufficient to give maximum fertilization is established in the oviducts within 1--2 h of mating, thereby affording protection from the uterine invasion of polymorphonuclear leucocytes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.